QuidelOrtho to Report Fourth Quarter and Full-Year 2025 Financial Results

QuidelOrtho (Nasdaq: QDEL) will report fourth quarter and full-year 2025 financial results for the period ended December 28, 2025, after market close on Wednesday, February 11, 2026.

Rhea-AI Summary

QuidelOrtho (Nasdaq: QDEL) will report fourth quarter and full-year 2025 financial results for the period ended December 28, 2025, after market close on Wednesday, February 11, 2026. A conference call will begin at 2:00 p.m. PT / 5:00 p.m. ET the same day, with presentation materials and a replay available in the Events & Presentations section of the company's Investor Relations website.

Investors can join the live webcast via the IR site or by phone at 833-470-1428 (U.S.) or +1 929-526-1599 (international) using Conference ID 690468.

Argus Jan 21 session

-10.11% close to close Open Argus

Details

News Market Reaction – QDEL

On Jan 21, the day this news came out, QDEL closed 10.11% below the previous close.

Data tracked by StockTitan Argus for the Jan 21 session.

Market Context

On Jan 21, the day this news came out, the stock closed 10.1% below the previous close. A negative r...

Analysis

On Jan 21, the day this news came out, the stock closed 10.1% below the previous close. A negative reaction despite a routine earnings-date announcement would fit a pattern where sentiment occasionally softens around updates even without new financial data, as seen after the December 2025 R&D podcast. With prior filings detailing significant goodwill impairment and restructuring charges, traders could have focused on existing risk factors. Moves of -5% or more around such dates have sometimes unwound once actual results and guidance were released.

Key Figures

Earnings release date: February 11, 2026 Fiscal year-end date: December 28, 2025 Conference call time PT: 2:00 p.m. PT +4 more

Earnings release date

February 11, 2026

Q4 and full-year 2025 results after market close

Fiscal year-end date

December 28, 2025

End of Q4 and full-year 2025 period

Conference call time PT

2:00 p.m. PT

Earnings call start time

Conference call time ET

5:00 p.m. ET

Earnings call start time

Domestic dial-in

833-470-1428

U.S. phone access to earnings call

International dial-in

+1 929-526-1599

International phone access to earnings call

Conference ID

690468

Code required to join earnings call by phone

Historical Context

5 past events · Latest: 2025-12-18

5 events

1. 2025-12-18

   R&D podcast

   24h Move

   -3.6%

   Science Bytes episode on advanced cardiac and GI diagnostics innovation.

2. 2025-11-24

   Investor conferences

   24h Move

   +9.2%

   Participation in two December 2025 healthcare investor conferences.

3. 2025-11-20

   Clinical podcast

   24h Move

   +1.5%

   Podcast on early detection and biomarkers in diabetes prevention.

4. 2025-11-18

   Product launch

   24h Move

   +0.8%

   Launch of QUICKVUE Influenza + SARS rapid combo test in the U.S.

5. 2025-11-05

   Earnings report

   24h Move

   +0.9%

   Q3 2025 results with adjusted profitability and narrowed full-year guidance.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

in vitro diagnostics

1 terms

in vitro diagnostics medical

"QuidelOrtho Corporation (Nasdaq: QDEL) ... a global leader of in vitro diagnostics"

In vitro diagnostics are medical tests performed on samples taken from the body—such as blood, urine or tissue—using instruments or kits outside the patient to detect disease, measure biomarkers or guide treatment decisions. They matter to investors because sales, regulatory approvals, reimbursement rules and adoption rates drive companies’ revenue and margins much like product launches and consumer demand in other industries; advances can create growth or disruption in healthcare markets.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SAN DIEGO, Jan. 21, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global leader of in vitro diagnostics, announced today that it will report its financial results for the fourth quarter and full year 2025 ended December 28, 2025, after the market close on Wednesday, February 11, 2026.

Following the release of financial results, QuidelOrtho will hold a conference call beginning at 2:00 p.m. PT / 5:00 p.m. ET to discuss its financial results. Interested parties can access the call from the "Events & Presentations" section of the "Investor Relations" page of the Company's website at https://ir.quidelortho.com. Presentation materials will also be posted to the "Events & Presentations" section of the "Investor Relations" page of the Company's website at the time of the call. Those unable to access the webcast may join the call via phone by dialing 833-470-1428 (domestic) or +1 929-526-1599 (international) and entering Conference ID number 690468.

A replay of the conference call will be available shortly after the event on the "Investor Relations" page of the Company's website under the "Events & Presentations" section.

QuidelOrtho is dedicated to advancing diagnostics to power a healthier future. For more information, please visit quidelortho.com and follow QuidelOrtho on LinkedIn, Facebook and X.

About QuidelOrtho Corporation

With expertise spanning clinical chemistry, immunoassay, immunohematology and molecular testing, QuidelOrtho Corporation (Nasdaq: QDEL) is a leading global provider of diagnostic solutions, dedicated to advancing fast, accurate and reliable results that help improve patient outcomes – from the point of care to hospital, lab to clinic. Building on a legacy of innovation, QuidelOrtho works with healthcare providers to advance diagnostics that connect insights with solutions, defining a clearer path for informed decisions and better care.

Investor Contact:
Juliet Cunningham
Vice President, Investor Relations
IR@QuidelOrtho.com

Media Contact:
D. Nikki Wheeler
Senior Director, Corporate Communications
media@QuidelOrtho.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/quidelortho-to-report-fourth-quarter-and-full-year-2025-financial-results-302666238.html

SOURCE QuidelOrtho Corporation

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will QuidelOrtho (QDEL) report its Q4 and full-year 2025 results?

QuidelOrtho will release results after market close on February 11, 2026 for the period ended December 28, 2025.

What time is the QuidelOrtho (QDEL) earnings conference call on February 11, 2026?

The call begins at 2:00 p.m. PT / 5:00 p.m. ET on February 11, 2026.

How can investors access the QuidelOrtho (QDEL) earnings webcast and materials?

Access the live webcast and presentation materials in the Events & Presentations section of QuidelOrtho's Investor Relations website.

What phone numbers and conference ID are provided for the QuidelOrtho (QDEL) call?

Dial 833-470-1428 (domestic) or +1 929-526-1599 (international) and enter Conference ID 690468.

Will a replay of the QuidelOrtho (QDEL) conference call be available?

Yes. A replay will be posted shortly after the event in the Events & Presentations section of the Investor Relations website.